Cutaquig® (Immune Globulin Subcutaneous (Human) - hipp)
for Primary Immunodeficiency Disorder
Cutaquig (Immune Globulin Subcutaneous (Human) - hipp) is used to treat primary immunodeficiency diseases and chronic inflammatory demyelinating polyneuropathy, an autoimmune disorder where the immune system attacks nerves, causing muscle weakness and numbness. It boosts the body's natural defense system against infections by providing antibodies (IgG) derived from healthy human blood. These antibodies help protect against infections and assist in fighting infections when they occur.
